![]() |
Volumn 52, Issue 11, 2013, Pages 1407-1409
|
Lower-dose thalidomide therapy effectively treats cutaneous lupus erythematosus but is limited by neuropathic toxicity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
THALIDOMIDE;
CHRONIC LYMPHATIC LEUKEMIA;
DISCOID LUPUS ERYTHEMATOSUS;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
ELECTROMYOGRAPHY;
HUMAN;
LETTER;
LEUKEMIA RELAPSE;
NERVE CONDUCTION;
NEUROTOXICITY;
PERIPHERAL NEUROPATHY;
SKIN LUPUS ERYTHEMATOSUS;
TREATMENT DURATION;
ADULT;
AGED;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LUPUS ERYTHEMATOSUS, DISCOID;
MALE;
MIDDLE AGED;
PARESTHESIA;
RECURRENCE;
RETROSPECTIVE STUDIES;
THALIDOMIDE;
WITHHOLDING TREATMENT;
|
EID: 84886740053
PISSN: 00119059
EISSN: 13654632
Source Type: Journal
DOI: 10.1111/j.1365-4632.2011.05200.x Document Type: Letter |
Times cited : (17)
|
References (6)
|